02.29.24 -- What Does The Catalent Acquisition By Novo Holdings Mean For The Biopharma Industry?

Companies aiming to accelerate biomanufacturing operations and use resources efficiently need access to technologies that can safely and efficiently complete their workflow from idea to injection.

Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.

Organoids, 3D models replicating human organs, are a growing topic of interest for researchers as they offer invaluable advantages, but they come with several challenges.

Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.

Learn how delivering HPAPI drugs in OSD form can help boost patient compliance and consider the formulation challenges inherent to HPAPI development and manufacturing.

Join global logistics leaders for an in-depth analysis of the evolving pharmaceutical supply chain, exploring critical issues, emerging trends, and strategies for navigating the complexities of 2024.

Selecting the right primary container for an injectable drug product is critical. Discover how to identify relevant testing to de-risk your product development — and quickly uncover causes of failures.

Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, patient compliance concerns, and more must be identified and addressed.

Find out about a platform for creating injectable and implantable long-acting drug delivery products, including its technical basics and how it can be used to deliver small molecules, peptides, and biologics.

Discover how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.

Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.

An isocratic USP monograph for ibuprofen and related organic impurities was used to assess a method migration between HPLC systems. Explore results that demonstrate the ability to migrate methods.

Supplying a fiberboard mockup allows a customer to make additional considerations before finalizing the design needed to enclose several processes requiring product manipulation in two or more “phases.”